Unicycive Therapeutics, Inc. (UNCY) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$6.5
Day's range
$7.11

Unicycive Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIVO CAPITAL, LLC 05/20/2026 1.79 M $11.78 M   0.00% 1.13%
MILLENNIUM MANAGEMENT LLC 05/15/2026 1.40 M $9.21 M   37.89% 0.88%
OCTAGON CAPITAL ADVISORS LP 05/15/2026 1.00 M $6.58 M   0.00% 0.63%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 939.20 K $6.18 M   0.00% 0.59%
05/15/2026 811.43 K $5.34 M   100.00% 0.51%
GREAT POINT PARTNERS LLC 05/15/2026 796.56 K $5.24 M   0.00% 0.50%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 473.56 K $3.12 M   0.00% 0.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 324.50 K $2.14 M   100.00% 0.20%
CITADEL ADVISORS LLC 05/15/2026 236.84 K $1.56 M   -8.31% 0.15%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 225.00 K $1.48 M   100.00% 0.14%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 203.74 K $1.34 M   18.95% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 199.22 K $1.31 M   699.08% 0.13%
MORGAN STANLEY 05/15/2026 188.18 K $1.24 M   303.96% 0.12%
MARSHALL WACE, LLP 05/15/2026 154.94 K $1.02 M   100.00% 0.10%
DAUNTLESS INVESTMENT GROUP, LLC 05/14/2026 147.09 K $967.83 K   64.50% 0.09%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 143.05 K $940.17 K   100.00% 0.09%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 119.53 K $786.51 K   19.84% 0.08%
DIADEMA PARTNERS LP 05/15/2026 106.08 K $698.03 K   100.00% 0.07%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 101.07 K $665.07 K   100.00% 0.06%
CITADEL ADVISORS LLC 05/15/2026 82.50 K $542.85 K   100.00% 0.05%
DIAMETRIC CAPITAL, LP 05/15/2026 80.36 K $528.78 K   100.00% 0.05%
STATE STREET CORP 05/15/2026 80.03 K $526.58 K   22.69% 0.05%
CANTOR FITZGERALD, L. P. 05/15/2026 75.00 K $493.50 K   -62.50% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 74.60 K $490.87 K   183.65% 0.05%
JANE STREET GROUP, LLC 05/12/2026 72.24 K $475.36 K   100.00% 0.05%
ACUTA CAPITAL PARTNERS, LLC 05/15/2026 57.96 K $381.37 K   -3.38% 0.04%
06/04/2026 55.70 K $366.51 K   100.00% 0.04%
BARCLAYS PLC 05/15/2026 50.00 K $329.00 K   62,400.00% 0.03%
JANE STREET GROUP, LLC 05/12/2026 42.70 K $280.97 K   100.00% 0.03%
HRT FINANCIAL LP 05/14/2026 41.49 K $273.00 K   100.00% 0.03%
JANE STREET GROUP, LLC 05/12/2026 41.20 K $271.10 K   97.13% 0.03%
NORTHERN TRUST CORP 05/14/2026 35.94 K $236.47 K   0.00% 0.02%
BLACKROCK, INC. 05/13/2026 35.90 K $236.24 K   -1.24% 0.02%
OMERS ADMINISTRATION CORP 05/15/2026 31.90 K $209.90 K   -59.21% 0.02%
BANK OF AMERICA CORP /DE/ 05/18/2026 29.53 K $194.31 K   19,327.63% 0.02%
QUADRATURE CAPITAL LTD 05/15/2026 27.92 K $183.69 K   -28.63% 0.02%
GOLDMAN SACHS GROUP INC 05/15/2026 27.09 K $178.27 K   100.00% 0.02%
PERSISTENT ASSET PARTNERS LTD 05/12/2026 26.83 K $176.52 K   100.00% 0.02%
VIRTU FINANCIAL LLC 05/14/2026 26.27 K $173.00 K   100.00% 0.02%
CITADEL ADVISORS LLC 05/15/2026 25.40 K $167.13 K   133.03% 0.02%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 24.40 K $160.55 K   100.00% 0.02%
XTX TOPCO LTD 05/15/2026 22.60 K $148.73 K   -36.16% 0.01%
CHICAGO PARTNERS INVESTMENT GROUP LLC 05/04/2026 21.78 K $167.91 K   -2.83% 0.01%
UBS GROUP AG 05/05/2026 19.44 K $127.94 K   -2.32% 0.01%
PRELUDE CAPITAL MANAGEMENT, LLC 05/15/2026 12.23 K $80.48 K   100.00% 0.01%
VANGUARD GLOBAL ADVISERS, LLC 05/08/2026 7.87 K $51.77 K   100.00% 0.01%
SIMPLEX TRADING, LLC 05/14/2026 5.82 K $38.30 K   100.00% 0.00%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 05/14/2026 1.60 K $10.53 K   220.00% 0.00%
SBI SECURITIES CO., LTD. 04/28/2026 557 $3.67 K   -0.18% 0.00%
ROYAL BANK OF CANADA 05/15/2026 377 $2.00 K   100.00% 0.00%

Unicycive Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 55 institutional investors and hedge funds held shares of Unicycive Therapeutics Inc. The most heavily invested institutionals were:

Vivo Capital, LLC: 1.79 M

MILLENNIUM MANAGEMENT LLC: 1.4 M

Octagon Capital Advisors LP: 1,000,000

Nantahala Capital Management, LLC: 939,202

GREAT POINT PARTNERS LLC: 796,558

Logos Global Management LP: 473,563

6.24% of Unicycive Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 9.92 M shares in the last 24 months. This purchase volume represents approximately $69.95 M in transactions.